Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 96-106

  Bei, Jin Xin ^a   Jia, Wei Hua ^a   Zeng, Yi Xin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Association; Genome wide; Linkage; Nasopharyngeal carcinoma; NPC; Susceptibility

Indexed keywords

CANCER SUSCEPTIBILITY; CARCINOGENESIS; CODON; CYP1A1 GENE; CYP2A13 GENE; CYP2A6 GENE; CYP2E1 GENE; ERCC1 GENE; ETHNICITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HOMOZYGOSITY; HUMAN; IMMUNOREGULATION; MDM2 GENE; MICROSATELLITE MARKER; MORPHOLOGY; N4BP2 GENE; NASOPHARYNX CARCINOMA; ONCOGENE; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE; UPREGULATION; XPD GENE; XRCC1 GENE; XRCC3 GENE;

CASE-CONTROL STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 84857789070     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.01.012     Document Type: Review

References (134)

1. Wei W.I., Sham J.S. Nasopharyngeal carcinoma. Lancet 2005, 365:2041-2054.
2. Ma J., Mai H.Q., Hong M.H., Cui N.J., Lu T.X., Lu L.X., et al. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations. Int J Radiat Oncol Biol Phys 2001, 50:1181-1189.
3. Xiao W.W., Huang S.M., Han F., Wu S.X., Lu L.X., Lin C.G., et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 2011, 117:1874-1883.
4. Heng D.M., Wee J., Fong K.W., Lian L.G., Sethi V.K., Chua E.T., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 1999, 86:1912-1920.
5. McDermott A.L., Dutt S.N., Watkinson J.C. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 2001, 26:82-92.
6. Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M., et al. Cancer incidence in five continents 2007, vol. IX. IARC Scientific Publication No. 160.
7. Li C.C., Yu M.C., Henderson B.E. Some epidemiologic observations of nasopharyngeal carcinoma in Guangdong, People's Republic of China. Natl Cancer Inst Monogr 1985, 69:49-52.
8. Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res 1974, 34:1189-1191.
9. Zeng Y.X., Jia W.H. Familial nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12:443-450.
10. Jia W.H., Feng B.J., Xu Z.L., Zhang X.S., Huang P., Huang L.X., et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer 2004, 101:363-369.
11. Levine P.H., Pocinki A.G., Madigan P., Bale S. Familial nasopharyngeal carcinoma in patients who are not Chinese. Cancer 1992, 70:1024-1029.
12. Wee J.T., Ha T.C., Loong S.L., Qian C.N. Is nasopharyngeal cancer really a " Cantonese cancer" ?. Chin J Cancer 2010, 29:517-526.
13. Liu P., Fang X., Feng Z., Guo Y.M., Peng R.J., Liu T., et al. Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol 2011, 85:11291-11299.
14. Henderson B.E., Louie E., SooHoo Jing J., Buell P., Gardner M.B. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 1976, 295:1101-1106.
15. Yu M.C., Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12:421-429.
16. Hildesheim A., Wang C.-P. Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000-2011. Rosetta Stone for NPC: Genetics, viral infection, and other environmental factors. Semin Cancer Biol 2012, 10.1016/j.semcancer.2012.01.007.
17. Chen C.J., Liang K.Y., Chang Y.S., Wang Y.F., Hsieh T., Hsu M.M., et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990, 10:547-553.
18. Jia W.H., Collins A., Zeng Y.X., Feng B.J., Yu X.J., Huang L.X., et al. Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China). Eur J Hum Genet 2005, 13:248-252.
19. Freimer N., Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 2004, 36:1045-1051.
20. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247.
21. Lu S.J., Day N.E., Degos L., Lepage V., Wang P.C., Chan S.H., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990, 346:470-471.
22. Simons M.J., Day N.E., Wee G.B., Shanmugaratnam K., Ho H.C., Wong S.H., et al. Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res 1974, 34:1192-1195.
23. Chan S.H., Day N.E., Kunaratnam N., Chia K.B., Simons M.J. HLA and nasopharyngeal carcinoma in Chinese - a further study. Int J Cancer 1983, 32:171-176.
24. Ooi E.E., Ren E.C., Chan S.H. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 1997, 74:229-232.
25. Lu C.C., Chen J.C., Jin Y.T., Yang H.B., Chan S.H., Tsai S.T. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 2003, 103:745-751.
26. Lu C.C., Chen J.C., Tsai S.T., Jin Y.T., Tsai J.C., Chan S.H., et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer 2005, 115:742-746.
27. Feng B.J., Huang W., Shugart Y.Y., Lee M.K., Zhang F., Xia J.C., et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002, 31:395-399.
28. Chen H., Feng B., Liang H., Zhang R., Zeng Y. The susceptibility gene for familial nasopharyngeal carcinoma is mapped on chromosome 4p11-p14 by haplotype analyses. Chin Sci Bull 2003, 48:2328-2331.
29. Jiang R.C., Qin H.D., Zeng M.S., Huang W., Feng B.J., Zhang F., et al. A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma. Cancer Res 2006, 66:693-700.
30. Xiong W., Zeng Z.Y., Xia J.H., Xia K., Shen S.R., Li X.L., et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004, 64:1972-1974.
31. Zhou X., Cui J., Macias V., Kajdacsy-Balla A.A., Ye H., Wang J., et al. The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics 2007, 57513.
32. Hu L.F., Qiu Q.H., Fu S.M., Sun D., Magnusson K., He B., et al. A genome-wide scan suggests a susceptibility locus on 5p13 for nasopharyngeal carcinoma. Eur J Hum Genet 2008, 16:343-349.
33. Pritchard J.K., Cox N.J. The allelic architecture of human disease genes: common disease-common variant... or not?. Hum Mol Genet 2002, 11:2417-2423.
34. Iles M.M. What can genome-wide association studies tell us about the genetics of common disease?. PLoS Genet 2008, 4:e33.
35. Chen J., Zheng H., Bei J.X., Sun L., Jia W.H., Li T., et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 2009, 85:775-785.
36. Xu S., Yin X., Li S., Jin W., Lou H., Yang L., et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 2009, 85:762-774.
37. Lo E.J., Bell D., Woo J.S., Li G., Hanna E.Y., El-Naggar A.K., et al. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 2010, 120:1990-1997.
38. Ma Y., Ohmen J.D., Li Z., Bentley L.G., McElree C., Pressman S., et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 1999, 5:271-278.
39. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213.
40. Simons M.J., Wee G.B., Day N.E., Morris P.J., Shanmugaratnam K., De-The G.B. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer 1974, 13:122-134.
41. Wu S.B., Hwang S.J., Chang A.S., Hsieh T., Hsu M.M., Hsieh R.P., et al. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 1989, 9:1649-1653.
42. Hu S.P., Day N.E., Li D.R., Luben R.N., Cai K.L., Ou-Yang T., et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005, 92:967-970.
43. Betuel H., Camoun M., Colombani J., Day N.E., Ellouz R., de-The G. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Cancer 1975, 16:249-254.
44. Herait P., Tursz T., Guillard M.Y., Hanna K., Lipinski M., Micheau C., et al. HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma. Tissue Antigens 1983, 22:335-341.
45. Moore S.B., Pearson G.R., Neel H.B., Weiland L.H. HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens 1983, 22:72-75.
46. Zervas J., Gregoriadis S., Tourlas D., Varlegidis E., Pantazopoulos P. Association between nasopharyngeal carcinoma and HLA antigens in Greeks. Panminerva Med 1983, 25:255-257.
47. Burt R.D., Vaughan T.L., McKnight B., Davis S., Beckmann A.M., Smith A.G., et al. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 1996, 5:879-887.
48. Mokni-Baizig N., Ayed K., Ayed F.B., Ayed S., Sassi F., Ladgham A., et al. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 2001, 61:55-58.
49. Dardari R., Khyatti M., Jouhadi H., Benider A., Ettayebi H., Kahlain A., et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 2001, 92:294-297.
50. Burt R.D., Vaughan T.L., Nisperos B., Swanson M., Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 1994, 56:465-467.
51. Hildesheim A., Apple R.J., Chen C.J., Wang S.S., Cheng Y.J., Klitz W., et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002, 94:1780-1789.
52. Ren E.C., Law G.C., Chan S.H. HLA-A2 allelic microvariants in nasopharyngeal carcinoma. Int J Cancer 1995, 63:213-215.
53. Pimtanothai N., Charoenwongse P., Mutirangura A., Hurley C.K. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand. Tissue Antigens 2002, 59:223-225.
54. Hirankarn N., Kimkong I., Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 2004, 64:588-592.
55. Yang Z.H., Dai Q., Zhong L., Zhang X., Guo Q.X., Li S.N. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2011, 50:208-214.
56. Zhu Y., Xu Y., Wei Y., Liang W., Liao M., Zhang L. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol (R Coll Radiol) 2008, 20:207-211.
57. Wei Y.S., Lan Y., Zhang L., Wang J.C. Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma. DNA Cell Biol 2010, 29:363-368.
58. Wei Y.S., Lan Y., Tang R.G., Xu Q.Q., Huang Y., Nong H.B., et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 2007, 125:309-317.
59. Wei Y.S., Kuang X.H., Zhu Y.H., Liang W.B., Yang Z.H., Tai S.H., et al. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 2007, 70:12-17.
60. Wei Y.S., Lan Y., Luo B., Lu D., Nong H.B. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 2009, 48:751-757.
61. Gao L.B., Liang W.B., Xue H., Rao L., Pan X.M., Lv M.L., et al. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta 2009, 409:132-135.
62. Nong L.G., Luo B., Zhang L., Nong H.B. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol 2009, 28:507-513.
63. Ben Nasr H., Chahed K., Mestiri S., Bouaouina N., Snoussi K., Chouchane L. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 2007, 68:761-769.
64. Ben Chaaben A., Busson M., Douik H., Boukouaci W., Mamoghli T., Chaouch L., et al. Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension. Tissue Antigens 2011, 78:148-151.
65. Pratesi C., Bortolin M.T., Bidoli E., Tedeschi R., Vaccher E., Dolcetti R., et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2006, 55:23-30.
66. Farhat K., Hassen E., Gabbouj S., Bouaouina N., Chouchane L. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 2008, 35:197-205.
67. Farhat K., Hassen E., Bouzgarrou N., Gabbouj S., Bouaouina N., Chouchane L. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 2008, 43:132-137.
68. Ho S.Y., Wang Y.J., Huang P.C., Tsai S.T., Chen C.H., Chen H.H., et al. Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-alpha gene and nasopharyngeal carcinoma. J Chin Med Assoc 2006, 69:351-357.
69. Tsai M.H., Chen W.C., Tsai F.J. Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal 2002, 16:146-150.
70. Sousa H., Breda E., Santos A.M., Catarino R., Pinto D., Medeiros R. Genetic risk markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha -308G>A polymorphism. DNA Cell Biol 2011, 30:99-103.
71. Jalbout M., Bouaouina N., Gargouri J., Corbex M., Ben Ahmed S., Chouchane L. Polymorphism of the stress protein HSP 70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 2003, 193:75-81.
72. He J.F., Jia W.H., Fan Q., Zhou X.X., Qin H.D., Shugart Y.Y., et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007, 7:194.
73. Song C., Chen L.Z., Zhang R.H., Yu X.J., Zeng Y.X. Functional variant in the 3'-untranslated region of toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer Biol Ther 2006, 5:1285-1291.
74. Zhou X.X., Jia W.H., Shen G.P., Qin H.D., Yu X.J., Chen L.Z., et al. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol Biomarkers Prev 2006, 15:862-866.
75. Xu Y.F., Liu W.L., Dong J.Q., Liu W.S., Feng Q.S., Chen L.Z., et al. Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in Cantonese. BMC Med Genet 2010, 11:161.
76. Xiao M., Qi F., Chen X., Luo Z., Zhang L., Zheng C., et al. Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogenet 2010, 37:27-32.
77. Zheng J., Liu B., Zhang L., Jiang L., Huang B., You Y., et al. The protective role of polymorphism MKK4 -1304T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Int J Cancer 2011, 10.1002/ijc.26253.
78. Ren W., Zheng H., Li M., Deng L., Li X.L., Pan K.F., et al. A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx. Cancer Genet Cytogenet 2005, 157:49-52.
79. Hassen E., Farhat K., Gabbouj S., Jalbout M., Bouaouina N., Chouchane L. TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet 2007, 175:41-46.
80. Tiwawech D., Srivatanakul P., Karalak A., Ishida T. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett 2006, 241:135-141.
81. Cheng Y.J., Chien Y.C., Hildesheim A., Hsu M.M., Chen I.H., Chuang J., et al. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2003, 12:179-180.
82. Jiang J.H., Jia W.H., Chen H.K., Feng B.J., Qin H.D., Pan Z.G., et al. Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population. J Transl Med 2004, 2:24.
83. Hildesheim A., Chen C.J., Caporaso N.E., Cheng Y.J., Hoover R.N., Hsu M.M., et al. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995, 4:607-610.
84. Hildesheim A., Anderson L.M., Chen C.J., Cheng Y.J., Brinton L.A., Daly A.K., et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997, 89:1207-1212.
85. Kongruttanachok N., Sukdikul S., Setavarin S., Kerekhjanarong V., Supiyaphun P., Voravud N., et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001, 1:4.
86. Guo X., Zeng Y., Deng H., Liao J., Zheng Y., Li J., et al. Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of nasopharyngeal carcinoma in a Han Chinese population of southern China. BMC Res Notes 2010, 3:212.
87. Jia W.H., Pan Q.H., Qin H.D., Xu Y.F., Shen G.P., Chen L., et al. A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 2009, 30:2031-2036.
88. Tiwawech D., Srivatanakul P., Karalak A., Ishida T. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev 2005, 6:270-275.
89. Guo X., O'Brien S.J., Zeng Y., Nelson G.W., Winkler C.A. GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev 2008, 17:1760-1763.
90. Frenkel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 1992, 53:127-166.
91. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A 2009, 106:2313-2318.
92. Cao Y., Miao X.P., Huang M.Y., Deng L., Hu L.F., Ernberg I., et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006, 6:167.
93. Yang Z.H., Du B., Wei Y.S., Zhang J.H., Zhou B., Liang W.B., et al. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol 2007, 26:491-496.
94. Cho E.Y., Hildesheim A., Chen C.J., Hsu M.M., Chen I.H., Mittl B.F., et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003, 12:1100-1104.
95. Laantri N., Jalbout M., Khyatti M., Ayoub W.B., Dahmoul S., Ayad M., et al. XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol Carcinog 2011, 50:732-737.
96. Yang Z.H., Dai Q., Kong X.L., Yang W.L., Zhang L. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2009, 48:196-201.
97. Zheng M.Z., Qin H.D., Yu X.J., Zhang R.H., Chen L.Z., Feng Q.S., et al. Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population. J Transl Med 2007, 5:36.
98. Qin H.D., Shugart Y.Y., Bei J.X., Pan Q.H., Chen L., Feng Q.S., et al. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011, 71:3000-3008.
99. Zheng J., Zhang C., Jiang L., You Y., Liu Y., Lu J., et al. Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma. Mol Carcinog 2011, 50:689-696.
100. Golovleva I., Birgander R., Sjalander A., Lundgren E., Beckman L. Interferon-alpha, p53 alleles involved in nasopharyngeal carcinoma. Carcinogenesis 1997, 18:645-647.
101. Xiao M., Zhang L., Zhu X., Huang J., Jiang H., Hu S., et al. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population. BMC Cancer 2010, 10:147.
102. Tsai M.H., Lin C.D., Hsieh Y.Y., Chang F.C., Tsai F.J., Chen W.C., et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 2002, 112:116-119.
103. Tiwawech D., Srivatanakul P., Karaluk A., Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett 2003, 198:69-75.
104. Zhou G., Zhai Y., Cui Y., Zhang X., Dong X., Yang H., et al. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 2007, 13:2627-2633.
105. Sousa H., Pando M., Breda E., Catarino R., Medeiros R. Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma. Mol Carcinog 2011, 50:73-79.
106. Zhou G., Zhai Y., Cui Y., Qiu W., Yang H., Zhang X., et al. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Hum Mutat 2007, 28:1091-1097.
107. Shao J.Y., Cao Y., Miao X.P., Huang M.Y., Deng L., Hao J.J., et al. A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China. Chin J Cancer 2011, 30:620-626.
108. Kondo S., Wakisaka N., Schell M.J., Horikawa T., Sheen T.S., Sato H., et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 2005, 115:368-376.
109. Nasr H.B., Mestiri S., Chahed K., Bouaouina N., Gabbouj S., Jalbout M., et al. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 2007, 384:57-63.
110. Zhang Y., Zhang H., Zhai Y., Wang Z., Ma F., Wang H., et al. A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. BMC Med 2011, 9:106.
111. Cao Y., Miao X.P., Huang M.Y., Deng L., Liang X.M., Lin D.X., et al. Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China. Mol Carcinog 2010, 49:928-934.
112. Tsou Y.A., Tsai C.W., Tsai M.H., Chang W.S., Li F.J., Liu Y.F., et al. Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan. Anticancer Res 2011, 31:3629-3632.
113. Zhou B., Rao L., Li Y., Gao L., Wang Y., Chen Y., et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 2009, 275:72-76.
114. Wei Y.S., Zhu Y.H., Du B., Yang Z.H., Liang W.B., Lv M.L., et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta 2007, 380:165-169.
115. He Y., Zhou G., Zhai Y., Dong X., Lv L., He F., et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet 2005, 42:172-176.
116. Ma F., Zhang H., Zhai Y., Huang W., Zhao C., Ou S., et al. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among Chinese. PLoS One 2011, 6:e16748.
117. Ben Nasr H., Chahed K., Bouaouina N., Chouchane L. PTGS2 (COX-2) -765G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 2009, 36:193-200.
118. Peng Z., Xie C., Wan Q., Zhang L., Li W., Wu S. Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma. Mitochondrion 2011, 11:327-333.
119. Bel Hadj Jrad B., Mahfouth W., Bouaouina N., Gabbouj S., Ahmed S.B., Ltaief M., et al. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett 2006, 233:21-27.
120. Zhu Q., Wang T., Ren J., Hu K., Liu W., Wu G. FAS-670A/G polymorphism: a biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese population. Clin Chim Acta 2010, 411:179-183.
121. Cao Y., Miao X.P., Huang M.Y., Deng L., Lin D.X., Zeng Y.X., et al. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma. Mol Carcinog 2010, 49:944-950.
122. Nasr H.B., Chahed K., Bouaouina N., Chouchane L. Functional vascular endothelial growth factor -2578C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Clin Chim Acta 2008, 395:124-129.
123. Wang T., Hu K., Ren J., Zhu Q., Wu G., Peng G. Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population. Mol Biol Rep 2010, 37:59-65.
124. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99.
125. Tse K.P., Su W.H., Chang K.P., Tsang N.M., Yu C.J., Tang P., et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 2009, 85:194-203.
126. Bei J.X., Li Y., Jia W.H., Feng B.J., Zhou G., Chen L.Z., et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010, 42:599-603.
127. Hirschhorn J.N., Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005, 6:95-108.
128. Ng C.C., Yew P.Y., Puah S.M., Krishnan G., Yap L.F., Teo S.H., et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 2009, 54:392-397.
129. Tse K.P., Su W.H., Yang M.L., Cheng H.Y., Tsang N.M., Chang K.P., et al. A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum Mol Genet 2011, 20:2889-2896.
130. Ioannidis J.P., Thomas G., Daly M.J. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009, 10:318-329.
131. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
132. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425.
133. Rivas M.A., Beaudoin M., Gardet A., Stevens C., Sharma Y., Zhang C.K., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43:1066-1073.
134. Simons M.J. Nasopharyngeal carcinoma as a paradigm of cancer genetics. Chin J Cancer 2011, 30:79-84.